Gopal et al. recruited 150 subjects with vitiligo and 100 control subjects and reported anti-TPO and anti-TG Ab positivity in 17 cases in contrast to eight control subjects (11.34% and 5.34%, respectively). The gene discussed is TPO; the disease is vitiligo.